Explore Our Diverse Range Of Offerings
From detailed reports to experts services offered in 15+ Industry Domains
Report
Press Release
Blogs
Industry Statistics
Add 2 More Reports For 20% off

Report Overview

The urinary incontinence market was valued at USD 13.62 Billion in 2025, driven by the increasing prevalence of urinary incontinence and rising awareness about available treatments across 8 major markets. The market is anticipated to grow at a CAGR of 6.40% during the forecast period of 2026-2035, with the values likely to reach USD 25.33 Billion by 2035.

Key Market Trends and Insights

  • Anticholinergic drugs led the treatment category, owing to their widespread use and established efficacy in managing urinary urgency and frequency symptoms.
  • Stress incontinence is poised to dominate the segment by incontinence type by holding over 30% of the global share.
  • Female patients accounted for the largest market share by gender.

Market Size and Forecast

  • Market Size (2025): USD 13.62 Billion 
  • Projected Market Size (2035): USD 25.33 Billion
  • CAGR (2026-2035): 6.40%
2025

Base Year

2019-2025

Historical Period

2026-2035

Forecast Period

  • The growing elderly population and rising prevalence of stress incontinence are expected to sustain strong demand for therapeutics and devices.

  • Advancements in wearable and discreet absorbent technologies are redefining user expectations, fueling innovation across the global incontinence product market.

  • Collaborations between healthcare providers and medtech companies are accelerating first-line care adoption, especially for female urinary incontinence in developed markets.

Compound Annual Growth Rate

6.4%

Value in USD Billion

2026-2035


*this image is indicative*

Urinary Incontinence Market Overview

Urinary incontinence refers to the unintentional leakage of urine, often resulting from weakened pelvic floor muscles, hormonal changes, or neurological conditions. According to Johns Hopkins Medicine, over 25 million adult Americans experience temporary or chronic urinary incontinence, with women twice as likely as men to be affected. Among women, stress incontinence and urge incontinence are the most common types, especially after childbirth or menopause. The condition impacts daily activities and emotional well-being, making early diagnosis and access to appropriate therapies essential for improving patient outcomes and quality of life.

Urinary Incontinence Market Growth Drivers

Clinician-Led Collaborations to Fuel Market Growth

In March  2025, Convatec announced an exclusive collaboration with the world’s largest wound, ostomy, and continence nursing organization. This partnership aims to advance clinical training, improve patient outcomes, and standardize incontinence care practices. As more clinicians adopt evidence-based protocols and rely on trusted brands, therapeutic device demand is poised to rise. By integrating specialist insights into product development and distribution, Convatec enhances provider trust and accelerates device adoption. These advancements are expected to drive robust growth in the urinary incontinence care market, particularly across institutional and homecare settings.

Emphasis on Early Detection to Boost Urinary Incontinence Market Value

In February  2025, Axena Health partnered with Mayo Clinic to improve early detection and treatment of female urinary incontinence through primary care education. This collaboration aims to provide digital learning modules and tools to support timely screening and treatment. As more primary care physicians become equipped to recognize symptoms early, treatment rates are projected to increase. This growing focus on first-line care is expected to expand product usage across devices, pharmaceuticals, and digital health platforms, driving long-term market development through enhanced access and improved patient outcomes.

Urinary Incontinence Market Trends

Major market trends include increasing preference on making products with discreet designs, surge in product launches with improved efficacy, and rising adoption of wearables and digital health, among others.

Discreet Designs and Patient Comfort Elevate Consumables Market Value

For instance, in June  2025, Ontex launched a new line of discreet incontinence products across Europe, offering slim pad profiles, odor control, and soft materials. These consumer-centric features cater to the growing demand for dignity-preserving, comfortable solutions for daily use. As aging populations seek lifestyle-aligned care, discreet consumables are gaining traction in both hospital and homecare settings. This trend underscores a shift from clinical utility to quality-of-life enhancement, contributing significantly to rising market value and competitive product differentiation across the global incontinence consumables landscape.

New Products with Enhanced Efficacy to Boost Urinary Incontinence Market Demand

In February  2025, Price Hanna Consultants released an independent study assessing leading absorbent incontinence products based on leakage protection, fluid retention, and skin safety. This transparency empowers both institutional buyers and consumers to make data-driven decisions. Brands that perform well in such third-party evaluations are gaining competitive advantage and trust, encouraging increased adoption across retail and clinical channels. This trend is accelerating product innovation and supporting long-term differentiation in the increasingly competitive urinary incontinence products market.

Rise in Wearables Adoption to Propel Urinary Incontinence Market Growth

In September  2022, Attindas Hygiene Partners introduced its new line of invisible disposable incontinence underwear designed for both men and women. These products feature ultra-thin absorbent cores and body-contouring designs that offer maximum discretion under clothing, directly addressing consumer demand for comfort, dignity, and normalcy in daily life. As patient preferences shift toward wearable, non-intrusive incontinence solutions, this launch reflects how innovation in design and material science is redefining consumer standards and significantly contributing to the growth and evolution of the global incontinence product market.

Digital Health Integration to Accelerate Innovation and Boost Urinary Incontinence Market Value

In October  2020, Essity introduced a comprehensive digital incontinence care solution combining wearable sensors, mobile analytics, and remote clinician engagement. This system enables real-time monitoring of wetness events, automated caregiver alerts, and personalized care feedback. As digital transformation reshapes healthcare delivery, such integrated solutions are revolutionizing incontinence care by promoting self-management and reducing caregiver burden. This trend reflects growing investment in smart health technologies, creating new value streams and strengthening innovation in the urinary incontinence management market.

Urinary Incontinence Market Share

Stress Incontinence to Lead the Market Share by Incontinence Type

The stress incontinence segment held the largest share in the market by incontinence type, accounting for 30%. This dominance is driven by the growing elderly population and the high prevalence of stress-related bladder issues, especially among postmenopausal women and individuals undergoing pelvic surgeries. Its commonality and early onset compared to other incontinence types contribute to higher diagnosis and treatment rates, further solidifying its position as the leading segment in terms of demand and revenue generation.

Urinary Incontinence Market Analysis by Region

The United States leads the market due to the high prevalence among women and the elderly, supported by advanced diagnostics and widespread treatment access. According to Johns Hopkins Medicine, one in four adult women in the U.S. experiences urinary leakage, creating strong demand for both pharmaceutical and device-based interventions. Japan ranks second, driven by its aging population and national long-term care insurance program, which subsidizes incontinence-related care and products, boosting demand across both institutional and home-based settings.

Urinary Incontinence Market: Competitive Landscape and Leading Players

The key features of the market report comprise clinical trials analysis, patent analysis, grants analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:

Pfizer, Inc.

Headquartered in New York and established in 1849, Pfizer Inc. is one of the world’s leading pharmaceutical companies. In the urinary incontinence market, Pfizer played a key role with its co-development of the anticholinergic drug tolterodine (Detrol), which was widely used to manage overactive bladder symptoms. Although Detrol is now off-patent, Pfizer continues to contribute to urology research, leveraging its expertise in neuroscience and genitourinary conditions through strategic collaborations and innovation platforms.

Astellas Pharma

Astellas Pharma, founded in 2005 and based in Tokyo, Japan, has established a robust presence in the urology space. Its flagship product, mirabegron (marketed as Myrbetriq), is a beta-3 adrenergic agonist widely prescribed for overactive bladder. The company has also invested in next-generation urology therapies, including fixed-dose combinations and gene therapies. Astellas continues to expand its footprint in the urinary incontinence market through targeted R&D and a commitment to improving patient outcomes in functional urology.

AbbVie

AbbVie, headquartered in North Chicago and spun off from Abbott Laboratories in 2013, is a prominent biopharmaceutical company. In the urinary incontinence market, AbbVie has gained traction through its collaboration with Medtronic and research in neurotoxins. The company’s interest in botulinum toxin-based therapies for overactive bladder and related conditions reflects its broader portfolio in neuroscience and chronic disease management. AbbVie continues to explore minimally invasive and long-acting therapies that address unmet needs in urological care.

Merck KGaA

Founded in 1668 and based in Darmstadt, Germany, Merck KGaA is a global science and technology company active in healthcare, life sciences, and performance materials. In the urinary incontinence space, Merck has contributed through its research in neuromodulation and bladder control mechanisms, as well as partnerships focused on digital health solutions. While not a primary player in anticholinergic drugs, the company’s innovation in precision medicine and drug delivery platforms supports advancements in incontinence and overactive bladder treatment.

*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*

Other players in the market include Sanofi S.A., Kissei Pharmaceutical, Kyorin Holding, Urovant Sciences, Teva Pharmaceutical Industries Ltd., Eli Lilly and Company, Ferring Pharmaceuticals, Coloplast Corp, B. Braun SE, Johnson & Johnson Medtech, Boston Scientific Corporation, and BD.

Urinary Incontinence Market Segmentation

The report offers a detailed analysis of the market based on the following segments:

Market Breakup by Incontinence Type

  • Urge Incontinence
  • Overflow Incontinence
  • Stress Incontinence
  • Mixed Incontinence
  • Others

Market Breakup by Treatment Type

  • Drugs
    • Anticholinergic
    • Beta-3 Adrenoceptor Agonists
    • Antidepressants
    • Alpha Blockers
    • Estrogens
    • Desmopressin
    • Others
  • Devices
    • Urinary Catheters
    • Vaginal and Urethral Slings
    • Electrical Stimulation Devices
    • Artificial Urinary Sphincters
    • Others

Market Breakup by Gender

  • Male
  • Female

Market Breakup by End User

  • Hospitals
  • Physician’s Office
  • Others

Market Breakup by Region

  • United States 
  • United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • India
  • Japan

Key Questions Answered in the Urinary Incontinence Market

  • What was the urinary incontinence market value in 2025?
  • What is the urinary incontinence market forecast outlook for 2026-2035?
  • What is market segmentation based on incontinence type?
  • What is the market breakup based on treatment type?
  • What is market segmentation based on gender?
  • What is market segmentation based on end user?
  • What are the major factors aiding the urinary incontinence market demand?
  • How has the market performed so far, and how is it anticipated to perform in the coming years?
  • What are the market's major drivers, opportunities, and restraints?
  • What are the major urinary incontinence market trends?
  • Which incontinence type will lead the market segment?
  • Which treatment type will lead the market segment?
  • Which gender will lead the market segment?
  • Which end use will lead the market segment?
  • Who are the key players involved in the urinary incontinence market?
  • What are the current unmet needs and challenges in the market?
  • How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping market dynamics?

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Looking for specific insights?

Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!

Report Summary

Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.

Key Highlights of the Report

Please note that the figures mentioned in the description serve as estimates and may vary from the actual figures presented in the final report.

REPORT FEATURES DETAILS
Base Year 2025
Historical Period 2019-2025
Forecast Period 2026-2035
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Incontinence Type
  • Treatment Type
  • Gender
  • End User
  • Region
Breakup by Incontinence Type
  • Urge Incontinence
  • Overflow Incontinence
  • Stress Incontinence
  • Mixed Incontinence
  • Others
Breakup by Treatment Type
  • Drugs
  • Devices
Breakup by Gender
  • Female
  • Male
Breakup by End User
  • Hospitals
  • Physician’s Office
  • Others
Breakup by Region
  • United States
  • United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • Japan
  • India
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • PESTEL Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Supplier Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Company News and Developments
    • Certifications
Companies Covered
  • Pfizer, Inc.
  • Astellas Pharma
  • AbbVie
  • Merck KGaA.
  • Sanofi S.A.
  • Kissei Pharmaceutical
  • Kyorin Holding
  • Urovant Sciences
  • Teva Pharmaceutical Industries Ltd.
  • Eli Lilly and Company
  • Ferring Pharmaceuticals
  • Coloplast Corp
  • B. Braun SE
  • Johnson & Johnson Medtech
  • Boston Scientific Corporation
  • BD

Datasheet

10 % Off

USD

3,299

2,969

Single User License

10 % Off

USD

5,499

4,949

Five User License

15 % Off

USD

6,999

5,949

Corporate License

15 % Off

USD

8,199

6,969

Datasheet

One User

USD 3,299

USD 2,969

tax inclusive*

  • Selected Segments
  • Printing Restrictions
  • Excel Spreadsheet Delivered via Email
  • Full Report
  • Periodic Updates
  • Post Sales Analysts Support
  • Unlimited Prints

Single User License

One User

USD 5,499

USD 4,949

tax inclusive*

  • All Segments
  • Printing Restrictions
  • PDF Delivered via Email
  • Custom Report Layout
  • Post Sales Analysts Support
  • Periodic Updates
  • Unlimited Prints

Five User License

Five User

USD 6,999

USD 5,949

tax inclusive*

  • All Segments
  • Five Prints Available
  • PDF Delivered via Email
  • Limited Free Customization
  • Post Sales Analyst Support
  • Custom Report Layout
  • Periodic Updates
  • Unlimited Prints

Corporate License

Unlimited Users

USD 8,199

USD 6,969

tax inclusive*

  • All Segments
  • Unlimited Prints Available
  • PDF & Excel Delivery via Email
  • Limited Free Customization
  • Post Sales Analysts Support
  • Discount On Next Update
  • Custom Report Layout

*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*

Bundle Type

Flash Bundle

20% OFF Number of Reports: 3

Small Business Bundle

25% OFF Number of Reports: 5

Growth Bundle

30% OFF Number of Reports: 8

Enterprise Bundle

35% OFF Number of Reports: 10
Overview
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complimentary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complimentary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 80 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complimentary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 100 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complimentary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards

*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*

Flash Bundle

Number of Reports: 3

20%

tax inclusive*

  • 3 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • Complimentary Excel Data Set
  • PPT Version of the Report
  • Power BI Dashboards
  • License Upgrade
  • Free Analyst Hours

Small Business Bundle

Number of Reports: 5

25%

tax inclusive*

  • 5 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • Complimentary Excel Data Set
  • PPT Version of the Report
  • Power BI Dashboards
  • License Upgrade

Growth Bundle

Number of Reports: 8

30%

tax inclusive*

  • 8 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • License Upgrade
  • Free Analyst Hours - 80 Hours
  • Power BI Dashboards

Enterprise Bundle

Number of Reports: 10

35%

tax inclusive*

  • 10 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • License Upgrade
  • Power BI Dashboards
  • Free Analyst Hours - 100 Hours

How To Order

This is a collaborative report by Vishakha Agrawal reflecting perspectives and research-driven insights from Expert Market Research.

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

License Type

Select License Type

Choose the right license for your needs and access rights.

shopping cart

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Strategic Solutions for Informed Decision-Making

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

We’re here to help answer any questions about our products and services.

Contact us